01 3Ciclesonide
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2016 Revenue in Millions : 48
2015 Revenue in Millions : 62
Growth (%) : -23
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2017 Revenue in Millions : 48
2016 Revenue in Millions : 102
Growth (%) : -53
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2018 Revenue in Millions : 0
2017 Revenue in Millions : 13
Growth (%) : -100%
LOOKING FOR A SUPPLIER?